A Review on Barriers of Medication Adherence in the Chronic Diseases

M Kumaraswamy,Dr Samraksha M,Dr Meghana M N,Dr Shreeharsha P B
DOI: https://doi.org/10.47583/ijpsrr.2022.v75i02.003
2022-08-15
International Journal of Pharmaceutical Sciences Review and Research
Abstract:Chronic illnesses are one of the world's most serious health problems, and the number of individuals affected is continually rising. Many of the most common chronic conditions, such as hypertension, diabetes, arthritis, and asthma, have a strong treatment component that includes medication adherence, physical exercise, and disease-specific behaviours. According to the World Health Organization (WHO), non-adherence is caused by five variables: socioeconomic factors, health-care system factors, therapy-related factors, condition-related factors, and patient-related factors. The results of treatment differed by 26% across patients with high and low adherence. Patients' morbidity, death, and preventable health-care expenses rise as a result of nonadherence. Lack of adherence was predicted to be responsible for almost 125,000 fatalities and 10% of hospitalizations in the United States in 2017. Low drug adherence is a major issue all around the world. In Hradec Kralove, the adherence rate to long-term drug therapy is reported to be between 40% and 50%. (Czech Republic). In the United States, more than 80% of persons aged 65 and up did not follow their prescription drug regimens, and more than half of patients using antihypertensive drugs ceased treatment within a year. Patients in India are only half as likely to take their medication as they should be, owing to a lack of effective education and patient counselling. Patients' timely medicine-taking behaviour has a greater impact on people's health than the need for new treatment options.
What problem does this paper attempt to address?